We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.25 | -6.58% | 17.75 | 17.50 | 18.00 | 18.25 | 17.75 | 18.25 | 160,602 | 10:30:44 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/11/2019 12:51 | CL Strange quote from a CEO when his primary function is to protect the shareholder lol | sentimentrules | |
20/11/2019 12:17 | CL spot on | humphries1 | |
20/11/2019 11:53 | This share will not go down to 40p. Too many people are aware of its phenomenal potential in the not too distant future. Share price at the moment is a true Bargain. Grab some while you can. | jamesrs1 | |
20/11/2019 11:46 | As Stephen O'Hara said I'm not trying to build a share price I'm trying to build a company | christopher logsdon | |
20/11/2019 11:44 | Patience required here. Peeps selling now are crazy. Why sell before any news, totally illogical. Walmart contract will happen. Stick with it guys. | fqr714bhp | |
20/11/2019 11:06 | Lolly ... that.s my thoughts but I smell a leak. Who.s singing like a canary? Geo ? An ex- employee? I.m thinking a raise is under way despite the protestations. Things dont add up. I.m sure I.ll be villified for daring to suggest such a thing but unofficial chat doesnt cut it - the mkt thinks tge same. | whitegold1 | |
20/11/2019 10:50 | Who knows really! My guess is lack of visibility re: full year revenues is behind current share price weakness. I'm slightly concerned by SOH's repeated referral to new sales booking legislation. If £1m+ FY sales achieved, but stock isn't all DELIVERED by year end, it could look like missed guidance. Whilst it's really only a short-term timing issue, I doubt investors would see it that way. Also, SBTX announcement has no numbers behind it. So no-one can gauge its significance (or lack thereof). The partner involved (Croda plc) has a turnover of c.£1.38bn and a market cap of £6.1bn. So you'd think the deal had potential. But without any numbers to guide us, who knows? | lord loads of lolly |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions